4//SEC Filing
Ambrose Kristen 4
Accession 0000875320-24-000041
CIK 0000875320other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:48 PM ET
Size
6.1 KB
Accession
0000875320-24-000041
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2024-02-09$422.74/sh−591$249,839→ 11,050 total - Sale
Common Stock
2024-02-12$420.24/sh−1,374$577,410→ 9,676 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms.Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001856587
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:48 PM ET
- Size
- 6.1 KB